Radiation Oncologist who treats and researches #prostatecancer, gastrointestinal cancers & benign diseases. Dabbles in #mathematics. Views my own.
Newcastle, Australia
Joined May 2012
- Tweets1.1K
- Following258
- Followers1.6K
- Likes868
Prof Jarad Martin retweeted
What a fun night at the UTDRO Alumni Reception during #ASTRO2026 in Boston! So great catching up with alumni, colleagues, and friends, sharing stories, and celebrating together. Huge congrats to all presenters, and our 2026 UTDRO Alumni Award recipient, Dr. @DocJarad !👏
Prof Jarad Martin retweeted
It's Prostate Cancer Awareness month & we want to thank the researchers & patients driving trials like TROG 18.01-NINJA, which is exploring if RT can be reduced from 20-40 sessions to 5 -14 sessions for some #prostatecancer patients!
@DocJarad
Read more: ap1.hubs.ly/H01j8sm0
Prof Jarad Martin retweeted
TODAY! ASTRO’s first ever Functional Radiation Medicine Grand Rounds
Join us on today, Thursday, Feb. 26 at 4:00 p.m. ET
Jarad Martin, PhD, ChB, MB, and Peter Gorayski, BMBS, present emerging evidence on the application of low-dose radiation therapy for nonmalignant conditions such as Osteoarthritis, Plantar Fasciitis, and Ledderhose Disease. @DocJarad @PeterGorayski
Organized by ASTRO's new Functional Radiation Medicine Task Force.
Register here for this FREE event: ow.ly/9FlM50Y3S9U
Prof Jarad Martin retweeted
Register FREE for ASTRO’s first Functional Radiation Medicine Grand Rounds
New Date - Join us on Thursday, February 26 at 4:00 p.m. ET!
Jarad Martin, PhD, ChB, MB, and Peter Gorayski, BMBS, present emerging evidence on the application of low-dose radiation therapy for nonmalignant conditions such as Osteoarthritis, Plantar Fasciitis, and Ledderhose Disease. @DocJarad @PeterGorayski
Organized by ASTRO's new Functional Radiation Medicine Task Force.
Register FREE for this inaugural event: ow.ly/9FlM50Y3S9U
Prof Jarad Martin retweeted
Register FREE for ASTRO’s first Functional Radiation Medicine Grand Rounds
Join us on Wednesday, February 25 at 4:00 p.m. ET as Jarad Martin, PhD, ChB, MB, and Peter Gorayski, BMBS, present emerging evidence on the application of low-dose radiation therapy for nonmalignant conditions such as Osteoarthritis, Plantar Fasciitis, and Ledderhose Disease. @DocJarad @PeterGorayski
Organized by ASTRO's new Functional Radiation Medicine Task Force.
Register FREE for this inaugural event: ow.ly/9FlM50Y3S9U
Prof Jarad Martin retweeted
Today our 2025 @ANZUPtrials Idea Generation Workshops continue with #ProstateCancer today led by #ProfLisaHorvath & @DocJarad with over 10 concepts being presented #ANZUPconcepts @PCFA @CancerAustralia @Prof_IanD
Prof Jarad Martin retweeted
Thanks for sharing!
The @ASTRO_org 2025 AM in San Francisco (Sep 27-Oct 1) will have a 3 hr symposium on Sun featuring RT for non-malignant disease, including cardiac. Your fellow Aussie, @DocJarad, is helping put it together. See you this Fall, if not sooner!
Our little Oz 🦘🇦🇺experience of cardiac ablation for 💔ventricular arrhythmia. 50-day author link here; authors.elsevier.com/c/1kiIB…. Pictures say a thousand words! Or in this case, re-wiring a few cardiac circuits 😀 @PeterMacRadOnc #radonc
ProPSMA - the gift that keeps on giving! Great to be part of such an impactful collaboration.
Longer follow-up from our landmark ProPSMA study just out @EurUrolOncol:
PSMA nodal status is prognostic! At 3 years 70% of patients without nodal involvement (N0) disease free, vs. only 46% if N1
CT-defined nodal status is not prognostic.
Read the details here: authors.elsevier.com/sd/arti…
Super team: @declangmurphy @veerukasi @ButeauJames @lawrentschuk @mj_robbo @DocJarad @mfrydenberg @DrAIravani
ProPSMA sponsored by @PeterMacCC
Funded by @PCFA @MovemberAUS
@pros_tic supported by @PCF_Science
Prof Jarad Martin retweeted
Delighted to share the results of #PACE B trial, published in @NEJM today
5 fraction SBRT is non inferior to CRT!
nejm.org/media/doi/full/10.1…
@alison_tree @ICR_CTSU @EmmaHall71 @royalmarsdenNHS @DrAndrewLoblaw @cpeedell @DrTolan @ProfJOSullivan @DrSuneil_PCa
Brachytherapy doses of radiotherapy delivered non-invasively for prostate cancer with 94.1% 5-year control and low rates of significant toxicity. Now being investigated in randomised trials such as @TROGfightcancer NINJA and @GETUG_Unicancer PEACE 7.
Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre Trial by @drericwegener et al
buff.ly/3Nc1hC5
#UroSoMe #MedTwitter #EUO
Prof Jarad Martin retweeted
#STORM trial examines elective nodal radiotherapy in treating #ProstateCancer recurrence. @piet_ost @ugent joins @zklaassen_md @GACancerCenter to discuss, emphasizing that ENRT offers longer disease-free periods and lower pelvic recurrence rates compared to SBRT. #WatchNow > bit.ly/3zVN60X
Prof Jarad Martin retweeted
Tell me again why we can’t use renal SBRT in the UK?!? 100% local control is hard to beat. Masterclass by @_ShankarSiva #ASTRO24
I struggle with when to consider testosterone replacement for symptomatic men with controlled disease after ADT. After either six or 18 months of ADT, spontaneous recovery is rare after the two year mark, so some great data to inform shared decision making.
Pleased to share the newest MARCAP publication, out in @EUplatinum -- the TRANSPORT analysis of T recovery after ADT for localized PCa, led by @weeloonong and Tahmineh Romero
Free share link: authors.elsevier.com/a/1joOX…
Prof Jarad Martin retweeted
Transdermal estradiol as a new option for testosterone lowering vs LHRHa :
similar MFS & OS but different toxicity than LHRHa (less hot flashes, higher bone mineral density...)
Open Qs:
1. efficacy vs antagonists
2. combination with other drugs (ARPI, PARPi) or RT
#ESMO2024
Prof Jarad Martin retweeted
#PACE A published in European Urology! SBRT vs Radical prostatectomy. Spread the word #SBRT should be discussed with eligible patients @DrTolan @alison_tree @cpeedell @DrAndrewLoblaw @EmmaHall71 @ProfJOSullivan authors.elsevier.com/sd/arti… – at Kensington, London
Prof Jarad Martin retweeted
Congratulations @ldawsonmd @RadMedPM @pmcancercentre @UHN @UofTDRO and colleagues across Canada for publishing CCTG HE1 in @TheLancetOncol establishing single fraction RT as an effective palliative treatment for painful liver cancer.
@CDNCancerTrials
thelancet.com/journals/lanon…
Prof Jarad Martin retweeted
Word of the Day: PSEUDOGLOT (neologism) - one who knows a few basic words in many languages and pretends to be a polyglot.
Great to see vHDRB going mainstream. Here is our data for 20Gy/2# boost - 94% efficacy, and low toxicity. Experimental arm in ongoing RCTs NINJA and PEACE 7.
sciencedirect.com/science/ar…
Prof Jarad Martin retweeted
100% agree @DrSpratticus
Here's a popular #HIFU company's web posting...
Vs data they reference vs other published data... (note their ref has no RP nor RT data). Yes failure def'n different for RP vs RT but drives salvage = more toxicity
Maybe they need to hire new webmaster?
Can’t emphasize the importance of this being done on trial as patients can’t have informed consent without good data.
All treatments have side effects and they need to understand their choices based on quality data and not misguided advertising that is rampant (including medonc and radonc for those thinking this is only urology groups).
Congratulations @_ShankarSiva. Super excited to have contributed to this important clinical trial, and looking forward to help roll renal #SBRT out as a standard management option for primary #RCC.
1/ For #KidneyCancerAwareness month @TheLancetOncol has a 50-day full link to @TROGfightcancer FASTRACK II! authors.elsevier.com/a/1ifvZ…. Thank you @CancerAustralia, @ANZUPtrials, @VarianMedSys. A new #radiotherapy standard of care option for inoperable primary #kidneycancer #radonc